Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis
Objective The outcome of participants with nephrotic syndrome in clinical trials of lupus nephritis has not been studied in detail.Methods Collated data from two randomised controlled trials in lupus nephritis, Lupus Nephritis Assessment of Rituximab (LUNAR) and A Study to Evaluate Ocrelizumab in Pa...
Saved in:
| Main Authors: | Brad Rovin, Maria Dall’Era, Paul Brunetta, Liliana Michelle Gomez Mendez, Matthew D Cascino, Tamiko R Katsumoto, Paul Brakeman, Jay Garg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/6/1/e000308.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lupus nephritis randomised controlled trials: evidence gaps and under-represented groups
by: Brad Rovin, et al.
Published: (2024-12-01) -
Roles of macrophages in lupus nephritis
by: Yaqian Cheng, et al.
Published: (2024-11-01) -
New Insights on Childhood Lupus Nephritis
by: Marchi-Silva R, et al.
Published: (2025-01-01) -
Classifying Lupus Nephritis: An Ongoing Story
by: Saba Kiremitci, et al.
Published: (2014-01-01) -
Intermediate monocytes in blood correlate with subclinical vascular changes in lupus nephritis
by: Sara S McCoy, et al.
Published: (2025-02-01)